Citations (98)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Rahul Singh, Vijay Kumar Bhardwaj, Jatin Sharma, Pralay Das & Rituraj Purohit. (2022) Identification of selective cyclin-dependent kinase 2 inhibitor from the library of pyrrolone-fused benzosuberene compounds: an in silico exploration. Journal of Biomolecular Structure and Dynamics 40:17, pages 7693-7701.
Read now
Read now
Denisse Arcos-Montoya, Talia Wegman-Ostrosky, Sonia Mejía-Pérez, Marisol De la Fuente-Granada, Ignacio Camacho-Arroyo, Alejandro García-Carrancá, Marco A Velasco-Velázquez, Joaquín Manjarrez-Marmolejo & Aliesha González-Arenas. (2021) Progesterone Receptor Together with PKCα Expression as Prognostic Factors for Astrocytomas Malignancy. OncoTargets and Therapy 14, pages 3757-3768.
Read now
Read now
Richard Voellmy, David C Bloom & Nuria Vilaboa. (2015) A novel approach for addressing diseases not yielding to effective vaccination? Immunization by replication-competent controlled virus. Expert Review of Vaccines 14:5, pages 637-651.
Read now
Read now
Christy R. Hagan, Tarah M. Regan, Gwen E. Dressing & Carol A. Lange. (2011) ck2-Dependent Phosphorylation of Progesterone Receptors (PR) on Ser81 Regulates PR-B Isoform-Specific Target Gene Expression in Breast Cancer Cells. Molecular and Cellular Biology 31:12, pages 2439-2452.
Read now
Read now
Andrea R Daniel, Christy R Hagan & Carol A Lange. (2011) Progesterone receptor action: defining a role in breast cancer. Expert Review of Endocrinology & Metabolism 6:3, pages 359-369.
Read now
Read now
Emily J. Faivre & Carol A. Lange. (2007) Progesterone Receptors Upregulate Wnt-1 To Induce Epidermal Growth Factor Receptor Transactivation and c-Src-Dependent Sustained Activation of Erk1/2 Mitogen-Activated Protein Kinase in Breast Cancer Cells. Molecular and Cellular Biology 27:2, pages 466-480.
Read now
Read now
Articles from other publishers (92)
Huijie Pu, Xiaosha Wen, DiXian Luo & Zifen Guo. (2023) Regulation of progesterone receptor expression in endometriosis, endometrial cancer, and breast cancer by estrogen, polymorphisms, transcription factors, epigenetic alterations, and ubiquitin-proteasome system. The Journal of Steroid Biochemistry and Molecular Biology 227, pages 106199.
Crossref
Crossref
Hui-Chen Wang, Yen-Nien Huo & Wen-Sen Lee. (2023) Activation of progesterone receptor is essential for folic acid-regulated cancer cell proliferation and migration. The Journal of Nutritional Biochemistry 112, pages 109205.
Crossref
Crossref
Chao Zhang, Xin Wang & Chuanbao Zhang. (2022) Icaritin inhibits CDK2 expression and activity to interfere with tumor progression. iScience 25:9, pages 104991.
Crossref
Crossref
Hanzhi Liang, Yue Zhu, Zhiyuan Zhao, Jintong Du, Xinying Yang, Hao Fang & Xuben Hou. (2022) Structure-Based Design of 2-Aminopurine Derivatives as CDK2 Inhibitors for Triple-Negative Breast Cancer. Frontiers in Pharmacology 13.
Crossref
Crossref
Lucie Malbeteau, Ha Thuy Pham, Louisane Eve, Michael R Stallcup, Coralie Poulard & Muriel Le Romancer. (2022) How Protein Methylation Regulates Steroid Receptor Function. Endocrine Reviews 43:1, pages 160-197.
Crossref
Crossref
Roser Zaurin, Roberto Ferrari, Ana Silvina Nacht, Jose Carbonell, Francois Le Dily, Jofre Font-Mateu, Lara Isabel de Llobet Cucalon, Enrique Vidal, Antonios Lioutas, Miguel Beato & Guillermo P Vicent. (2021) A set of accessible enhancers enables the initial response of breast cancer cells to physiological progestin concentrations. Nucleic Acids Research 49:22, pages 12716-12731.
Crossref
Crossref
Yassmin Medina-Laver, Cristina Rodríguez-Varela, Stefania Salsano, Elena Labarta & Francisco Domínguez. (2021) What Do We Know about Classical and Non-Classical Progesterone Receptors in the Human Female Reproductive Tract? A Review. International Journal of Molecular Sciences 22:20, pages 11278.
Crossref
Crossref
Stefania Salsano, Roberto González-Martín, Alicia Quiñonero, Silvia Pérez-Debén & Francisco Domínguez. (2021) Deciphering the Role of PGRMC1 During Human Decidualization Using an In Vitro Approach. The Journal of Clinical Endocrinology & Metabolism 106:8, pages 2313-2327.
Crossref
Crossref
Kevin D. Freeman-Cook, Robert L. Hoffman, Douglas C. Behenna, Britton Boras, Jordan Carelli, Wade Diehl, Rose Ann Ferre, You-Ai He, Andrea Hui, Buwen Huang, Nanni Huser, Rhys Jones, Susan E. Kephart, John Lapek, Michele McTigue, Nichol Miller, Brion W. Murray, Asako Nagata, Lisa Nguyen, Sherry Niessen, Sacha Ninkovic, Inish O’Doherty, Martha A. Ornelas, James Solowiej, Scott C. Sutton, Khanh Tran, Elaine Tseng, Ravi Visswanathan, Meirong Xu, Luke Zehnder, Qin Zhang, Cathy Zhang & Stephen Dann. (2021) Discovery of PF-06873600, a CDK2/4/6 Inhibitor for the Treatment of Cancer. Journal of Medicinal Chemistry 64:13, pages 9056-9077.
Crossref
Crossref
Paweł Łukasik, Michał Załuski & Izabela Gutowska. (2021) Cyclin-Dependent Kinases (CDK) and Their Role in Diseases Development–Review. International Journal of Molecular Sciences 22:6, pages 2935.
Crossref
Crossref
Nozomi Jimura, Kazuyasu Fujii, Zhiwei Qiao, Ryuto Tsuchiya, Yuki Yoshimatsu, Tadashi Kondo & Takuro Kanekura. (2021) Kinome profiling analysis identified Src pathway as a novel therapeutic target in combination with histone deacetylase inhibitors for cutaneous T-cell lymphoma. Journal of Dermatological Science 101:3, pages 194-201.
Crossref
Crossref
Amy R. Dwyer, Thu H. Truong, Carlos Perez Kerkvliet, Kiran V. Paul, Peter Kabos, Carol A. Sartorius & Carol A. Lange. (2020) Insulin receptor substrate-1 (IRS-1) mediates progesterone receptor-driven stemness and endocrine resistance in oestrogen receptor+ breast cancer. British Journal of Cancer 124:1, pages 217-227.
Crossref
Crossref
Solomon Tadesse, Abel T. Anshabo, Neil Portman, Elgene Lim, Wayne Tilley, C. Elizabeth Caldon & Shudong Wang. (2020) Targeting CDK2 in cancer: challenges and opportunities for therapy. Drug Discovery Today 25:2, pages 406-413.
Crossref
Crossref
Mauro E. Cenciarini & Cecilia J. Proietti. (2019) Molecular mechanisms underlying progesterone receptor action in breast cancer: Insights into cell proliferation and stem cell regulation. Steroids 152, pages 108503.
Crossref
Crossref
Teeranut Asavasupreechar, Ryoko Saito, Dean P. Edwards, Hironobu Sasano & Viroj Boonyaratanakornkit. (2019) Progesterone receptor isoform B expression in pulmonary neuroendocrine cells decreases cell proliferation. The Journal of Steroid Biochemistry and Molecular Biology 190, pages 212-223.
Crossref
Crossref
Merit L. Goodman, Gloria M. Trinca, Katherine R. Walter, Evangelia K. Papachristou, Clive S. D’Santos, Tianbao Li, Qi Liu, Zhao Lai, Prabhakar Chalise, Rashna Madan, Fang Fan, Mary A. Markiewicz, Victor X. Jin, Jason S. Carroll & Christy R. Hagan. (2019) Progesterone Receptor Attenuates STAT1-Mediated IFN Signaling in Breast Cancer. The Journal of Immunology 202:10, pages 3076-3086.
Crossref
Crossref
Solomon Tadesse, Elizabeth C. Caldon, Wayne Tilley & Shudong Wang. (2018) Cyclin-Dependent Kinase 2 Inhibitors in Cancer Therapy: An Update. Journal of Medicinal Chemistry 62:9, pages 4233-4251.
Crossref
Crossref
Radek Jorda, Denisa Hendrychová, Jiří Voller, Eva Řezníčková, Tomáš Gucký & Vladimír Kryštof. (2018) How Selective Are Pharmacological Inhibitors of Cell-Cycle-Regulating Cyclin-Dependent Kinases?. Journal of Medicinal Chemistry 61:20, pages 9105-9120.
Crossref
Crossref
Radek Jorda, Zuzana Bučková, Eva Řezníčková, Jan Bouchal & Vladimír Kryštof. (2018) Selective inhibition reveals cyclin-dependent kinase 2 as another kinase that phosphorylates the androgen receptor at serine 81. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1865:2, pages 354-363.
Crossref
Crossref
Todd P. Knutson, Thu H. Truong, Shihong Ma, Nicholas J. Brady, Megan E. Sullivan, Ganesh Raj, Kathryn L. Schwertfeger & Carol A. Lange. (2017) Posttranslationally modified progesterone receptors direct ligand-specific expression of breast cancer stem cell-associated gene programs. Journal of Hematology & Oncology 10:1.
Crossref
Crossref
Kamila Kitowska, Agnieszka Kowalska, Magdalena Mieszkowska, Dominika Piasecka, Andrzej Skladanowski, Hanna Romanska & Rafal Sadej. (2017) Progesterone impairs Herceptin effect on breast cancer cells. Oncology Letters.
Crossref
Crossref
Brenda Marquina-Sánchez, Jesús González-Jorge, Valeria Hansberg-Pastor, Talia Wegman-Ostrosky, Noemi Baranda-Ávila, Sonia Mejía-Pérez, Ignacio Camacho-Arroyo & Aliesha González-Arenas. (2017) The interplay between intracellular progesterone receptor and PKC plays a key role in migration and invasion of human glioblastoma cells. The Journal of Steroid Biochemistry and Molecular Biology 172, pages 198-206.
Crossref
Crossref
RuiQi Chen, Yue Yu & Xuesen Dong. (2017) Progesterone receptor in the prostate: A potential suppressor for benign prostatic hyperplasia and prostate cancer. The Journal of Steroid Biochemistry and Molecular Biology 166, pages 91-96.
Crossref
Crossref
Ignacio Camacho-Arroyo, Valeria Hansberg-Pastor, Edgar Ricardo Vázquez-Martínez & Marco Cerbón. 2017. Hormones, Brain and Behavior. Hormones, Brain and Behavior
181
214
.
Chun-Ting Kuo & Wen-Sen Lee. (2016) Progesterone receptor activation is required for folic acid-induced anti-proliferation in colorectal cancer cell lines. Cancer Letters 378:2, pages 104-110.
Crossref
Crossref
G.P. Vicent, R.H.G. Wright & M. Beato. (2016) Linker histones in hormonal gene regulation. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 1859:3, pages 520-525.
Crossref
Crossref
Lindsey S. Treviño, Michael J. Bolt, Sandra L. Grimm, Dean P. Edwards, Michael A. Mancini & Nancy L. Weigel. (2016) Differential Regulation of Progesterone Receptor-Mediated Transcription by CDK2 and DNA-PK. Molecular Endocrinology 30:2, pages 158-172.
Crossref
Crossref
Tarin M. Bigley, Justin M. Reitsma & Scott S. Terhune. (2015) Antagonistic Relationship between Human Cytomegalovirus pUL27 and pUL97 Activities during Infection. Journal of Virology 89:20, pages 10230-10246.
Crossref
Crossref
Heidi N. Hilton, J. Dinny Graham & Christine L. Clarke. (2015) Minireview: Progesterone Regulation of Proliferation in the Normal Human Breast and in Breast Cancer: A Tale of Two Scenarios?. Molecular Endocrinology 29:9, pages 1230-1242.
Crossref
Crossref
Zhiqi Song, Jingrong Lin, Zhe Sun, Jing Ni & Yang Sha. (2015) RNAi-mediated downregulation of CDKL1 inhibits growth and colony-formation ability, promotes apoptosis of human melanoma cells. Journal of Dermatological Science 79:1, pages 57-63.
Crossref
Crossref
Ana Gordon, José C Garrido-Gracia, Rafaela Aguilar & José E Sánchez-Criado. (2015) Understanding the regulation of pituitary progesterone receptor expression and phosphorylation. REPRODUCTION 149:6, pages 615-623.
Crossref
Crossref
Caroline H Diep, Andrea R Daniel, Laura J Mauro, Todd P Knutson & Carol A Lange. (2015) Progesterone action in breast, uterine, and ovarian cancers. Journal of Molecular Endocrinology 54:2, pages R31-R53.
Crossref
Crossref
Marcela A. Bennesch & Didier Picard. (2015) Minireview: Tipping the Balance: Ligand-Independent Activation of Steroid Receptors. Molecular Endocrinology 29:3, pages 349-363.
Crossref
Crossref
Aliesha González-ArenasMiguel Ángel Peña-OrtizValeria Hansberg-PastorBrenda Marquina-SánchezNoemi Baranda-Ávila, Karen Nava-CastroAlejandro Cabrera-WroomanJesús González-JorgeIgnacio Camacho-Arroyo. (2015) PKCα and PKCδ Activation Regulates Transcriptional Activity and Degradation of Progesterone Receptor in Human Astrocytoma Cells. Endocrinology 156:3, pages 1010-1022.
Crossref
Crossref
Maria Loreto Bravo, Mauricio P. Pinto, Ibeth Gonzalez, Barbara Oliva, Sumie Kato, Mauricio A. Cuello, Carol A. Lange & Gareth I. Owen. (2014) Progesterone regulation of tissue factor depends on MEK1/2 activation and requires the proline-rich site on progesterone receptor. Endocrine 48:1, pages 309-320.
Crossref
Crossref
Alicia A Goyeneche & Carlos M Telleria. (2015) Antiprogestins in gynecological diseases. REPRODUCTION 149:1, pages R15-R33.
Crossref
Crossref
Christy R Hagan & Carol A Lange. (2014) Molecular determinants of context-dependent progesterone receptor action in breast cancer. BMC Medicine 12:1.
Crossref
Crossref
T Sato, T H Tran, A R Peck, M A Girondo, C Liu, C R Goodman, L M Neilson, B Freydin, I Chervoneva, T Hyslop, A J Kovatich, J A Hooke, C D Shriver, S Y Fuchs & H Rui. (2013) Prolactin suppresses a progestin-induced CK5-positive cell population in luminal breast cancer through inhibition of progestin-driven BCL6 expression. Oncogene 33:17, pages 2215-2224.
Crossref
Crossref
Todd P. Knutson & Carol A. Lange. (2014) Tracking progesterone receptor-mediated actions in breast cancer. Pharmacology & Therapeutics 142:1, pages 114-125.
Crossref
Crossref
Hany A. Abdel-Hafiz & Kathryn B. Horwitz. (2014) Post-translational modifications of the progesterone receptors. The Journal of Steroid Biochemistry and Molecular Biology 140, pages 80-89.
Crossref
Crossref
Hwa Hwa Chung, Siu Kwan Sze, Amanda Rui En Woo, Yang Sun, Kae Hwan Sim, Xue Ming Dong & Valerie C-L. Lin. (2014) Lysine Methylation of Progesterone Receptor at Activation Function 1 Regulates both Ligand-independent Activity and Ligand Sensitivity of the Receptor. Journal of Biological Chemistry 289:9, pages 5704-5722.
Crossref
Crossref
Aliesha González-Arenas, Alejandro Cabrera-Wrooman, Néstor Fabián Díaz, Tania Karina González-García, Ivan Salido-Guadarrama, Mauricio Rodríguez-Dorantes & Ignacio Camacho-Arroyo. (2014) Progesterone Receptor Subcellular Localization and Gene Expression Profile in Human Astrocytoma Cells Are Modified by Progesterone. Nuclear Receptor Research 1.
Crossref
Crossref
Christy R. Hagan, Todd P. Knutson & Carol A. Lange. (2013) A Common Docking Domain in Progesterone Receptor-B links DUSP6 and CK2 signaling to proliferative transcriptional programs in breast cancer cells. Nucleic Acids Research 41:19, pages 8926-8942.
Crossref
Crossref
Lindsey S. Treviño & Nancy L. Weigel. (2013) Phosphorylation: a fundamental regulator of steroid receptor action. Trends in Endocrinology & Metabolism 24:10, pages 515-524.
Crossref
Crossref
Shaohui Wang, Ying Li, Pang-Hung Hsu, Sou-Ying Lee, Yoon Kim & Eva Y.-H.P. Lee. (2013) Progesterone Receptor A Stability Is Mediated by Glycogen Synthase Kinase-3β in the Brca1-deficient Mammary Gland. Journal of Biological Chemistry 288:36, pages 26265-26274.
Crossref
Crossref
Aihua Hu, Maureen B. Josephson, Barry L. Diener, Gustavo Nino, Shuyun Xu, Chinmay Paranjape, Jordan S. Orange & Michael M. Grunstein. (2013) Pro-Asthmatic Cytokines Regulate Unliganded and Ligand-Dependent Glucocorticoid Receptor Signaling in Airway Smooth Muscle. PLoS ONE 8:4, pages e60452.
Crossref
Crossref
David M. W. Cork, Thomas W. J. Lennard & Alison J. Tyson-Capper. (2012) Progesterone receptor (PR) variants exist in breast cancer cells characterised as PR negative. Tumor Biology 33:6, pages 2329-2340.
Crossref
Crossref
Jorge Diaz, Evelyn Aranda, Soledad Henriquez, Marisol Quezada, Estefanía Espinoza, Maria Loreto Bravo, Bárbara Oliva, Soledad Lange, Manuel Villalon, Marius Jones, Jan J Brosens, Sumie Kato, Mauricio A Cuello, Todd P Knutson, Carol A Lange, Lisette Leyton & Gareth I Owen. (2012) Progesterone promotes focal adhesion formation and migration in breast cancer cells through induction of protease-activated receptor-1. Journal of Endocrinology 214:2, pages 165-175.
Crossref
Crossref
Tamara Tanos, Lucia Jimenez Rojo, Pablo Echeverria & Cathrin Brisken. (2012) ER and PR signaling nodes during mammary gland development. Breast Cancer Research 14:4.
Crossref
Crossref
Li TangYanfang GaoFeng YanJinhai Tang. (2012) Evaluation of Cyclin-Dependent Kinase-Like 1 Expression in Breast Cancer Tissues and Its Regulation in Cancer Cell Growth. Cancer Biotherapy and Radiopharmaceuticals 27:6, pages 392-398.
Crossref
Crossref
Christy R. Hagan, Andrea R. Daniel, Gwen E. Dressing & Carol A. Lange. (2012) Role of phosphorylation in progesterone receptor signaling and specificity. Molecular and Cellular Endocrinology 357:1-2, pages 43-49.
Crossref
Crossref
Junaid A. KhanLarbi AmazitCatherine BellanceAnne Guiochon-Mantel, Marc Lombès & Hugues Loosfelt. (2011) p38 and p42/44 MAPKs Differentially Regulate Progesterone Receptor A and B Isoform Stabilization. Molecular Endocrinology 25:10, pages 1710-1724.
Crossref
Crossref
Nicolette J.D. Verhoog, Andrea Du Toit, Chanel Avenant & Janet P. Hapgood. (2011) Glucocorticoid-independent Repression of Tumor Necrosis Factor (TNF) α-stimulated Interleukin (IL)-6 Expression by the Glucocorticoid Receptor. Journal of Biological Chemistry 286:22, pages 19297-19310.
Crossref
Crossref
Guillermo Pablo Vicent, A. Silvina Nacht, Jofre Font-Mateu, Giancarlo Castellano, Laura Gaveglia, Cecilia Ballaré & Miguel Beato. (2011) Four enzymes cooperate to displace histone H1 during the first minute of hormonal gene activation. Genes & Development 25:8, pages 845-862.
Crossref
Crossref
Cecilia J. Proietti, Wendy Béguelin, María Celeste Díaz Flaqué, Florencia Cayrol, Martín A. Rivas, Mercedes Tkach, Eduardo H. Charreau, Roxana Schillaci & Patricia V. Elizalde. (2011) Novel role of signal transducer and activator of transcription 3 as a progesterone receptor coactivator in breast cancer. Steroids 76:4, pages 381-392.
Crossref
Crossref
Guillermo P. Vicent, A. Silvina Nacht, Roser Zaurín, Cecilia Ballaré, Jaime Clausell & Miguel Beato. (2010) Minireview: Role of Kinases and Chromatin Remodeling in Progesterone Signaling to Chromatin. Molecular Endocrinology 24:11, pages 2088-2098.
Crossref
Crossref
Mary Ellen PavoneScott ReierstadHui Sun, Magdy MiladSerdar E. BulunYou-Hong Cheng. (2010) Altered Retinoid Uptake and Action Contributes to Cell Survival in Endometriosis. The Journal of Clinical Endocrinology & Metabolism 95:11, pages E300-E309.
Crossref
Crossref
Anastasia Kariagina, Jianwei Xie, Jeffrey R. Leipprandt & Sandra Z. Haslam. (2010) Amphiregulin Mediates Estrogen, Progesterone, and EGFR Signaling in the Normal Rat Mammary Gland and in Hormone-Dependent Rat Mammary Cancers. Hormones and Cancer 1:5, pages 229-244.
Crossref
Crossref
Nathan J. Charles, Peter Thomas & Carol A. Lange. (2010) Expression of Membrane Progesterone Receptors (mPR/PAQR) in Ovarian Cancer Cells: Implications for Progesterone-Induced Signaling Events. Hormones and Cancer 1:4, pages 167-176.
Crossref
Crossref
Marisol Quezada, Jorge Diaz, Soledad Henriquez, Maria Loreto Bravo, Evelyn Aranda, Barbara Oliva, Manuel Villalon, Sumie Kato, Mauricio A. Cuello, Jan J. Brosens, Carol A. Lange & Gareth I. Owen. (2010) 2-Methoxyestradiol Inhibits Progesterone-Dependent Tissue Factor Expression and Activity in Breast Cancer Cells. Hormones and Cancer 1:3, pages 117-126.
Crossref
Crossref
Shaila Mani & Wendy Portillo. (2010) Activation of progestin receptors in female reproductive behavior: Interactions with neurotransmitters. Frontiers in Neuroendocrinology 31:2, pages 157-171.
Crossref
Crossref
Junling Chen, Beum-Soo An, Wai-Kin So, Linan Cheng, Geoffrey L. Hammond & Peter C. K. Leung. (2010) Gonadotropin-Releasing Hormone-I-Mediated Activation of Progesterone Receptor Contributes to Gonadotropin α-Subunit Expression in Mouse Gonadotrophs. Endocrinology 151:3, pages 1204-1211.
Crossref
Crossref
Chanel AvenantAndrea KotitschkeJanet P. Hapgood. (2010) Glucocorticoid Receptor Phosphorylation Modulates Transcription Efficacy through GRIP-1 Recruitment. Biochemistry 49:5, pages 972-985.
Crossref
Crossref
Andrea Kotitschke, Hanél Sadie-Van Gijsen, Chanel Avenant, Sandra Fernandes & Janet P. Hapgood. (2009) Genomic and Nongenomic Cross Talk between the Gonadotropin-Releasing Hormone Receptor and Glucocorticoid Receptor Signaling Pathways. Molecular Endocrinology 23:11, pages 1726-1745.
Crossref
Crossref
Robert D. Ward & Nancy L. Weigel. (2009) Steroid receptor phosphorylation: Assigning function to site-specific phosphorylation. BioFactors 35:6, pages 528-536.
Crossref
Crossref
Andrea R. Daniel, Todd P. Knutson & Carol A. Lange. (2009) Signaling inputs to progesterone receptor gene regulation and promoter selectivity. Molecular and Cellular Endocrinology 308:1-2, pages 47-52.
Crossref
Crossref
Andrea R. Daniel & Carol A. Lange. (2009) Protein kinases mediate ligand-independent derepression of sumoylated progesterone receptors in breast cancer cells. Proceedings of the National Academy of Sciences 106:34, pages 14287-14292.
Crossref
Crossref
Pragati Katiyar, Yongxian Ma, Anna Riegel, Saijun Fan & Eliot M. Rosen. (2009) Mechanism of BRCA1-Mediated Inhibition of Progesterone Receptor Transcriptional Activity. Molecular Endocrinology 23:8, pages 1135-1146.
Crossref
Crossref
Beum-Soo An, Song Ling Poon, Wai-Kin So, Geoffrey L. Hammond & Peter C.K. Leung. (2009) Rapid Effect of GNRH1 on Follicle-Stimulating Hormone Beta Gene Expression in LbetaT2 Mouse Pituitary Cells Requires the Progesterone Receptor1. Biology of Reproduction 81:2, pages 243-249.
Crossref
Crossref
S.K. Mani & B.W. O’Malley. 2009. Hormones, Brain and Behavior. Hormones, Brain and Behavior
1467
1504
.
M.J. Tetel & C.A. Lange. 2009. Hormones, Brain and Behavior. Hormones, Brain and Behavior
1439
1466
.
Ellis R. Levin. 2009. Hormone Receptors in Breast Cancer. Hormone Receptors in Breast Cancer
1
10
.
Sebastián Giulianelli, Juan P. Cerliani, Caroline A. Lamb, Victoria T. Fabris, María C. Bottino, María A. Gorostiaga, Virginia Novaro, Adrián Góngora, Alberto Baldi, Alfredo Molinolo & Claudia Lanari. (2008) Carcinoma-associated fibroblasts activate progesterone receptors and induce hormone independent mammary tumor growth: A role for the FGF-2/FGFR-2 axis. International Journal of Cancer 123:11, pages 2518-2531.
Crossref
Crossref
Kevin Lee, Jinrong Wang & Francesco DeMayo. 2008. Endometrium, The. Endometrium, The
176
192
.
Grazia Arpino, Lisa Wiechmann, C. Kent Osborne & Rachel Schiff. (2008) Crosstalk between the Estrogen Receptor and the HER Tyrosine Kinase Receptor Family: Molecular Mechanism and Clinical Implications for Endocrine Therapy Resistance. Endocrine Reviews 29:2, pages 217-233.
Crossref
Crossref
Carol A LangeDouglas Yee. (2008) Progesterone and Breast Cancer. Women's Health 4:2, pages 151-162.
Crossref
Crossref
Carol A. Lange. (2008) Integration of progesterone receptor action with rapid signaling events in breast cancer models. The Journal of Steroid Biochemistry and Molecular Biology 108:3-5, pages 203-212.
Crossref
Crossref
Carol A. Lange, Carol A. Sartorius, Hany Abdel-Hafiz, Monique A. Spillman, Kathryn B. Horwitz & Britta M. Jacobsen. 2008. Innovative Endocrinology of Cancer. Innovative Endocrinology of Cancer
94
111
.
A. Leung, F. Geng, A. Daulny, G. Collins, P. Guzzardo & W. P. Tansey. 2009. The Ubiquitin System in Health and Disease. The Ubiquitin System in Health and Disease
75
97
.
Andrea R. Daniel, Emily J. Faivre & Carol A. Lange. (2007) Phosphorylation-Dependent Antagonism of Sumoylation Derepresses Progesterone Receptor Action in Breast Cancer Cells. Molecular Endocrinology 21:12, pages 2890-2906.
Crossref
Crossref
Thomas L. McCarthy, Richard B. Hochberg, David C. Labaree & Michael Centrella. (2007) 3-Ketosteroid Reductase Activity and Expression by Fetal Rat Osteoblasts. Journal of Biological Chemistry 282:47, pages 34003-34012.
Crossref
Crossref
Nancy L. Weigel & Nicole L. Moore. (2007) Steroid Receptor Phosphorylation: A Key Modulator of Multiple Receptor Functions. Molecular Endocrinology 21:10, pages 2311-2319.
Crossref
Crossref
Carol A. LangeDaniel GioeliStephen R. HammesPaul C. Marker. (2007) Integration of Rapid Signaling Events with Steroid Hormone Receptor Action in Breast and Prostate Cancer. Annual Review of Physiology 69:1, pages 171-199.
Crossref
Crossref
Nicole L. Moore, Ramesh Narayanan & Nancy L. Weigel. (2007) Cyclin dependent kinase 2 and the regulation of human progesterone receptor activity. Steroids 72:2, pages 202-209.
Crossref
Crossref
Andrea R. Daniel, Ming Qiu, Emily J. Faivre, Julie Hanson Ostrander, Andrew Skildum & Carol A. Lange. (2007) Linkage of progestin and epidermal growth factor signaling: Phosphorylation of progesterone receptors mediates transcriptional hypersensitivity and increased ligand-independent breast cancer cell growth. Steroids 72:2, pages 188-201.
Crossref
Crossref
N.L. Weigel & N.L. Moore. (2007) Cyclins, cyclin dependent kinases, and regulation of steroid receptor action. Molecular and Cellular Endocrinology 265-266, pages 157-161.
Crossref
Crossref
Nancy L. Weigel & Nicole L. Moore. (2018) Kinases and protein phosphorylation as regulators of steroid hormone action. Nuclear Receptor Signaling 5:1, pages nrs.05005.
Crossref
Crossref
K. Lee, J. Jeong, M.-J. Tsai, S. Tsai, J.P. Lydon & F.J. DeMayo. (2006) Molecular mechanisms involved in progesterone receptor regulation of uterine function. The Journal of Steroid Biochemistry and Molecular Biology 102:1-5, pages 41-50.
Crossref
Crossref
Beum-Soo An, David M. Selva, Geoffrey L. Hammond, Adolfo Rivero-Muller, Nafis Rahman & Peter C.K. Leung. (2006) Steroid Receptor Coactivator-3 Is Required for Progesterone Receptor Trans-activation of Target Genes in Response to Gonadotropin-releasing Hormone Treatment of Pituitary Cells. Journal of Biological Chemistry 281:30, pages 20817-20824.
Crossref
Crossref
C. A. Lange. (2006) Review of: Human progesterone receptor displays cell cycle-dependent changes in transcriptional activity. Breast Cancer Online 9:02.
Crossref
Crossref
Mariam H. Al-Dhaheri & Brian G. Rowan. (2006) Application of Phosphorylation Site-Specific Antibodies to Measure Nuclear Receptor Signaling: Characterization of Novel Phosphoantibodies for Estrogen Receptor α. Nuclear Receptor Signaling 4:1, pages nrs.04007.
Crossref
Crossref
Kimberly K. Leslie & Carol A. Lange. (2005) Breast Cancer and Pregnancy. Obstetrics and Gynecology Clinics of North America 32:4, pages 547-558.
Crossref
Crossref